Also known as Cancer Of Esophagus and Esophagus Cancer
Esophageal cancer (or oesophageal cancer) is malignancy of the esophagus. There are various subtypes, primarily squamous cell cancer (approx 90–95% of all esophageal cancer worldwide) and adenocarcinoma (approx. 50–80% of all esophageal cancer in the United States). Squamous cell cancer arises from the cells that line the upper part of the esophagus. Adenocarcinoma arises from glandular cells that are present at the junction of the esophagus and stomach.Source: Wikipedia
Within all the people who go to their doctor with esophageal cancer, 32% report having fatigue, 32% report having weakness, and 32% report having ache all over.
Patients with esophageal cancer often receive hematologic tests, complete blood count, radiographic imaging procedure, glucose measurement, x-ray computed tomography, electrolytes panel, complete physical skin exam performed (ml) and therapeutic radiology for cancer treatment .
The most commonly prescribed drugs for patients with esophageal cancer include metoclopramide, cisplatin, prochlorperazine (compro), dexamethasone topical product, fluorouracil, aprepitant (emend), dexamethasone, heparin, paclitaxel (taxol), sucralfate (carafate), sennosides, usp (perdiem), mirtazapine and palonosetron (aloxi) .
|Dexamethasone Topical Product|
|Sennosides, Usp (Perdiem)||$9|
Groups of people at highest risk for esophageal cancer include age 75+ years, sex == male and age 60-74 years. On the other hand, age 1-4 years, age 15-29 years, and age < 1 years almost never get esophageal cancer.